Trial Details
AVAILABLEBasic Information
| Clinical ID | c1192 |
|---|---|
| Identifier | NCT06856135 |
| Trial Title | Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Ulcerative Colitis |
| Interventions | DRUG: Vedolizumab IV |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | EXPANDED_ACCESS |
|---|---|
| Phase | - |
Time Information
| Start Date | - |
|---|---|
| Primary Completion Date | - |
| Completion Date | - |